I Don’t Believe a Person Has to Die When Trying to Get High: Overdose Prevention and Response Strategies in Rural Illinois
Authors:
- Suzan M. WaltersSWSuzan M. Walters
- Marisa FelsherMFMarisa Felsher
- David FrankDFDavid Frank
- Jessica JaiswalJJJessica Jaiswal
- Tarlise TownsendTTTarlise Townsend
- Brandon MuncanBMBrandon Muncan
- Alex S. BennettABAlex S. Bennett
- Samuel R. FriedmanSamuel R. Friedman
- Wiley JenkinsWiley Jenkins
- Mai T. PhoMPMai T. Pho
- Scott FletcherSFScott Fletcher
- Danielle C. OmpadDODanielle C. Ompad
Open Access
- 16 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (2) , 1648
Abstract
Background: Overdose is a leading cause of morbidity and mortality among people who inject drugs. Illicitly manufactured fentanyl is now a major driver of opioid overdose deaths. Methods: Semi-structured interviews were conducted with 23 participants (19 persons who inject drugs and 4 service providers) from rural southern Illinois. Data were analyzed using constant comparison and theoretical sampling methods. Results: Participants were concerned about the growing presence of fentanyl in both opioids and stimulants, and many disclosed overdose experiences. Strategies participants reported using to lower overdose risk included purchasing drugs from trusted sellers and modifying drug use practices by partially injecting and/or changing the route of transmission. Approximately half of persons who inject drugs sampled had heard of fentanyl test strips, however fentanyl test strip use was low. To reverse overdoses, participants reported using cold water baths. Use of naloxone to reverse overdose was low. Barriers to naloxone access and use included fear of arrest and opioid withdrawal. Conclusions: People who inject drugs understood fentanyl to be a potential contaminant in their drug supply and actively engaged in harm reduction techniques to try to prevent overdose. Interventions to increase harm reduction education and information about and access to fentanyl test strips and naloxone would be beneficial.Keywords
Funding Information
- the NIH Clinical and Translational Science Awards Program (UL1TR001445, K01DA053159, P30DA01104, T32 DA007233-31, 4UH3DA044829-03)
- National Institute on Drug Abuse (UL1TR001445, K01DA053159, P30DA01104, T32 DA007233-31, 4UH3DA044829-03)
This publication has 66 references indexed in Scilit:
- Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural CountiesThe Milbank Quarterly, 2015
- Rural/Urban Residence, Access, and Perceived Need for Treatment Among African American Cocaine UsersThe Journal of Rural Health, 2014
- Changing Law from Barrier to Facilitator of Opioid Overdose Prevention2013
- Drug Market Reconstitution after Hurricane Katrina: Lessons for Local Drug Abuse Control InitiativesJustice Research and Policy, 2011
- Protecting Respondent Confidentiality in Qualitative ResearchQualitative Health Research, 2009
- A qualitative study of overdose responses among Chicago IDUsHarm Reduction Journal, 2008
- Comparison of Characteristics of Opioid-Using Pregnant Women in Rural and Urban SettingsThe American Journal of Drug and Alcohol Abuse, 2008
- Differences in Prevalence of Prescription Opiate Misuse Among Rural and Urban ProbationersThe American Journal of Drug and Alcohol Abuse, 2007
- From Salt Injection to Naloxone: Accuracy and Myths in Peer Resuscitation Methods for Opiate OverdoseJournal of Drug Issues, 2002
- The key informant techniqueFamily Practice, 1996